• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国特应性皮炎抗过敏药物研发:当前方法与未来策略。

Anti-allergic drug discovery in China for eczema: current methods and future strategies.

机构信息

The Chinese University of Hong Kong, Prince of Wales Hospital, Department of Pediatrics, Clinical Sciences Building, 6/F, Shatin, Hong Kong, China.

出版信息

Expert Opin Drug Discov. 2013 Jul;8(7):753-67. doi: 10.1517/17460441.2013.795539. Epub 2013 May 6.

DOI:10.1517/17460441.2013.795539
PMID:23642103
Abstract

INTRODUCTION

Eczema is a common childhood atopic disease associated with chronicity and impaired quality of life. As there is no cure for this disease, treatment relies on topical and systemic anti-allergic or immunomodulating therapies. Topical corticosteroids, macrolide immunosuppressants and oral immunomodulating drugs have been the mainstay for the treatment of recalcitrant disease. However, in China as well as throughout Asia, the use of traditional and proprietary topical and herbal medicines is also popular.

AREAS COVERED

This article reviews the evidence for the anti-allergic effects of topical and oral forms of these medicinal. The authors also present and discuss the current methods of preparation and evaluation for these traditional and proprietary medications. Additionally, the authors present the novel delivery method of employing nanotechnology to deliver these herbal therapies.

EXPERT OPINION

Many herbal concoctions have had trials which have claimed therapeutic benefits for eczema. However, the scientific methods in these trials are often flawed and often not objective. In fact, the majority of these trials do not provide proof of objective efficacy for the anti-allergic effects claimed. It is felt that the delivery of herbal medication by nanotechnology has several crucial challenges that certainly need to be overcome for the optimal design of therapies for eczema, through optimizing material properties, methods of delivery and understanding the mechanisms of action.

摘要

简介

湿疹是一种常见的儿童特应性疾病,与慢性疾病和生活质量受损有关。由于这种疾病无法治愈,因此治疗依赖于局部和全身抗过敏或免疫调节疗法。局部皮质类固醇、大环内酯类免疫抑制剂和口服免疫调节药物一直是治疗顽固疾病的主要方法。然而,在中国乃至整个亚洲,传统和专利的局部和草药药物的使用也很流行。

涵盖领域

本文综述了这些药物的局部和口服形式的抗过敏作用的证据。作者还介绍和讨论了这些传统和专利药物的当前制备和评估方法。此外,作者还提出了利用纳米技术来输送这些草药疗法的新的传递方法。

专家意见

许多草药制剂已经进行了试验,声称对湿疹有治疗作用。然而,这些试验中的科学方法往往存在缺陷,而且往往不客观。事实上,这些试验中的大多数都没有为声称的抗过敏作用提供客观疗效的证据。人们认为,通过纳米技术输送草药药物存在几个关键挑战,这些挑战肯定需要通过优化材料特性、输送方法和了解作用机制来克服,以便为湿疹的治疗提供最佳设计。

相似文献

1
Anti-allergic drug discovery in China for eczema: current methods and future strategies.中国特应性皮炎抗过敏药物研发:当前方法与未来策略。
Expert Opin Drug Discov. 2013 Jul;8(7):753-67. doi: 10.1517/17460441.2013.795539. Epub 2013 May 6.
2
Eczema therapeutics in children: what do the clinical trials say?儿童湿疹治疗方法:临床试验有何发现?
Hong Kong Med J. 2015 Jun;21(3):251-60. doi: 10.12809/hkmj144474. Epub 2015 Apr 23.
3
Challenges for drug discovery and development in China.中国药物研发面临的挑战。
Expert Opin Drug Discov. 2017 Jan;12(1):105-113. doi: 10.1080/17460441.2017.1257115. Epub 2016 Nov 24.
4
An update on anti-allergic patents granted in China: 2009 - 2011.中国抗过敏专利授权的最新进展:2009-2011 年。
Expert Opin Ther Pat. 2012 Jul;22(7):715-34. doi: 10.1517/13543776.2012.696100. Epub 2012 Jun 16.
5
The historical basis of a misconception leading to undertreating atopic dermatitis (eczema): facts and controversies.导致特应性皮炎(湿疹)治疗不足的误解的历史基础:事实与争议。
Clin Dermatol. 2010 Jan-Feb;28(1):45-51. doi: 10.1016/j.clindermatol.2009.03.009.
6
Use of ceramides and related products for childhood-onset eczema.神经酰胺及相关产品在儿童期湿疹中的应用。
Recent Pat Inflamm Allergy Drug Discov. 2013 Jan 1;7(1):12-9.
7
[Comparative clinical trials of three topical preparations in various forms of eczema].[三种不同剂型外用制剂治疗各类湿疹的比较性临床试验]
Hautarzt. 1973 Dec;24(12):555-8.
8
[Diagnostic, prophylactic and therapeutic guidelines in patients with atopic dermatitis. Position paper by the task force of the National Specialists on Dermatology, Venereology and Allergology].[特应性皮炎患者的诊断、预防和治疗指南。国家皮肤科、性病学和过敏学专家工作组立场文件]
Pol Merkur Lekarski. 2004;17 Suppl 3:3-15.
9
Treatment for seasonal allergic rhinitis by Chinese herbal medicine: a randomized placebo controlled trial.中药治疗季节性变应性鼻炎:一项随机安慰剂对照试验
Altern Ther Health Med. 2003 Sep-Oct;9(5):80-7.
10
[Key technologies elements of clinical study of traditional Chinese medicine new drugs on children's dermatitis and eczema].
Zhongguo Zhong Yao Za Zhi. 2013 Jun;38(11):1840-3.

引用本文的文献

1
Gallic Acid Is the Major Active Component of Cortex Moutan in Inhibiting Immune Maturation of Human Monocyte-Derived Dendritic Cells.没食子酸是牡丹皮抑制人单核细胞衍生树突状细胞免疫成熟的主要活性成分。
Molecules. 2015 Sep 10;20(9):16388-403. doi: 10.3390/molecules200916388.